These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11921176)

  • 1. The partnership between breast cancer advocates and scientists.
    Platner JH; Bennett LM; Millikan R; Barker MD
    Environ Mol Mutagen; 2002; 39(2-3):102-7. PubMed ID: 11921176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast Cancer Survivor Advocacy at a University Hospital: Development of a Peer Support Program with Evaluation by Patients, Advocates, and Clinicians.
    Mirrielees JA; Breckheimer KR; White TA; Denure DA; Schroeder MM; Gaines ME; Wilke LG; Tevaarwerk AJ
    J Cancer Educ; 2017 Mar; 32(1):97-104. PubMed ID: 26477478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advocacy groups for breast cancer patients.
    Waller M; Batt S
    CMAJ; 1995 Mar; 152(6):829-33. PubMed ID: 7697576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The perspective of African-American breast cancer survivor-advocates.
    Lythcott N; Green BL; Kramer Brown Z
    Cancer; 2003 Jan; 97(1 Suppl):324-8. PubMed ID: 12491496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and implementation of a science training course for breast cancer activists: Project LEAD (leadership, education and advocacy development).
    Dickersin K; Braun L; Mead M; Millikan R; Wu AM; Pietenpol J; Troyan S; Anderson B; Visco F
    Health Expect; 2001 Dec; 4(4):213-20. PubMed ID: 11703495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A national cancer control program: the 'Down Under' experience with breast cancer.
    Luxford K; Zorbas H
    Cancer Causes Control; 2009 Feb; 20(1):105-14. PubMed ID: 18791801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiences of breast cancer survivor-advocates and advocates in countries with limited resources: a shared journey in breast cancer advocacy.
    Errico KM; Rowden D
    Breast J; 2006; 12 Suppl 1():S111-6. PubMed ID: 16430394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoting Scientist-Advocate Collaborations in Cancer Research: Why and How.
    Salamone JM; Lucas W; Brundage SB; Holloway JN; Stahl SM; Carbine NE; London M; Greenwood N; Goyes R; Chisholm DC; Price E; Carlin R; Winarsky S; Baker KB; Maues J; Shajahan-Haq AN
    Cancer Res; 2018 Oct; 78(20):5723-5728. PubMed ID: 30120210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supporting cancer survivors' participation in peer review: perspectives from NCI's CARRA program.
    Gilkey MB
    J Cancer Surviv; 2014 Mar; 8(1):114-20. PubMed ID: 24214497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The history of breast cancer advocacy.
    Braun S
    Breast J; 2003; 9 Suppl 2():S101-3. PubMed ID: 12713506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Project CHARGE: building an urban health policy advocacy community.
    Chin JJ; Abesamis-Mendoza N
    Prog Community Health Partnersh; 2012; 6(1):17-23. PubMed ID: 22643784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiatives of 11 rural Appalachian cancer coalitions in Pennsylvania and New York.
    Kluhsman BC; Bencivenga M; Ward AJ; Lehman E; Lengerich EJ
    Prev Chronic Dis; 2006 Oct; 3(4):A122. PubMed ID: 16978497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Policy and advocacy in the quest for effective translational breast care research.
    La Fargue MM
    Breast; 2010 Aug; 19(4):303-6. PubMed ID: 20399093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancer.
    Trosman JR; Weldon CB; Schink JC; Gradishar WJ; Benson AB
    J Comp Eff Res; 2013 Jul; 2(4):461-77. PubMed ID: 24236686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Europa DONNA, the European Breast Cancer Coalition: lobbying at European and local levels.
    Buchanan M; O'Connell D; Mosconi P
    J Ambul Care Manage; 2004; 27(2):146-53. PubMed ID: 15069993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative impact of including consumers in the scientific review of breast cancer research proposals.
    Andejeski Y; Bisceglio IT; Dickersin K; Johnson JE; Robinson SI; Smith HS; Visco FM; Rich IM
    J Womens Health Gend Based Med; 2002 May; 11(4):379-88. PubMed ID: 12150500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing disparities through coalition building: Alabama REACH 2010 lessons learned.
    Wynn TA; Johnson RE; Fouad M; Holt C; Scarinci I; Nagy C; Partridge E; Dignan MB; Person S; Parham G
    J Health Care Poor Underserved; 2006 May; 17(2 Suppl):55-77. PubMed ID: 16809875
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.